Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-03-25

Clinical Trial Update: Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes [NA]

View source ↗

Summary

A clinical trial examining clotrimazole and hydroxyurea in patients with sickle cell syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clotrimazole (clotrimazole)
  • HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Sickle Cell Anemia | NA | Status: COMPLETED